| 000 | 01597 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516035958.0 | ||
| 264 | 0 | _c20110906 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2011.04.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNurmio, Mirja | |
| 245 | 0 | 0 |
_aReceptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cAug 2011 |
||
| 300 |
_a267-79 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBone Development _xdrug effects |
| 650 | 0 | 4 |
_aBone Resorption _xchemically induced |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aJoki, Henna | |
| 700 | 1 | _aKallio, Jenny | |
| 700 | 1 | _aMäättä, Jorma A | |
| 700 | 1 | _aVäänänen, H Kalervo | |
| 700 | 1 | _aToppari, Jorma | |
| 700 | 1 | _aJahnukainen, Kirsi | |
| 700 | 1 | _aLaitala-Leinonen, Tiina | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 254 _gno. 3 _gp. 267-79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2011.04.019 _zAvailable from publisher's website |
| 999 |
_c20848582 _d20848582 |
||